Calliditas’ Nephrology Gem Tarpeyo Faces EU Regulatory Delay
CHMP Has Manufacturing Questions
The Swedish biotech’s oral corticosteroid for a kidney disorder has left the EMA’s CHMP with questions on its manufacturing, delaying an EU approval opinion that had been slated for the first quarter.
